No Detail Found!

Role of Asymmetrical Dimethyl Arginine in Cardiovascular Diabetology.

Author(s)
Kalsoom Tariq Department of Bio-Chemistry, Khyber Medical College, Peshawar, Pakistan
Mudassir Ahmad Khan Department of Bio-Chemistry, Khyber Medical College, Peshawar, Pakistan
Naheed Khattak Department of Bio-Chemistry, Khyber Medical College, Peshawar, Pakistan
Abstract
Objective: To determine the serum ADMA level and association of different biochemical parameters with ADMA in diabetes mellitus patients with and without coronary artery disease and normal healthy individuals. Material and Methods: A total of 210 patients ,out of which 70 type 2 diabetics without coronary artery disease in group B and 70 type 2 diabetics with CAD in group C are included. 70 normal control individuals in group A were also enrolled in the study. Blood was obtained from each participant for biochemical analysis of fasting blood sugar (FBS), glycated hemoglobin (HbA1c), total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride (TG) and asymmetrical dimethyl arginine (ADMA). Results: An elevated ADMA was noted in diabetic subjects with and without coronary artery disease than the healthy control group (03.9±1.5µmol/L and 02.0±0.6 Vs. 0.6±0.2 µmol/L). Similarly different parameters like FBS, HbA1c, HDL, LDL-C Triglyceride were found to be elevated in groupB and group C as compared to group A. Conclusion: All biochemical parameters are found to be increased in both the diseased groups i.e type 2 diabetes mellitus without CAD and type 2 diabetes mellitus with CAD as compared to the normal healthy individuals.
Publication Details
Page(s) 131-136
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 25, Issue: 1, Year: 2017

Request the full text from PASTIC

References
ChanNN,VallanceP,ColhounHM, .Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control,Arterioscler Thromb Vasc Biol. -
.,2003 Jun 1 1048 -54
2003.Does statin treatment influence plasma ADMA levels? Atheroscler Suppl, 4 19 -22
LePerticoneF,SciacquaA,MaioR,PerticoneM,MaasR,BogerRH, 2005.Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension,J Am Coll Cardiol 46 518 -23
Heart, 2005., 91 731 -36
Rang , H. P.,Dale , M.,Ritter,Mandelstam , J.,Weber , M.,Cunnane , T.C.,Williams , R.J.P, 2000.M. and,Fourth Edition 392 -197
CriddleDN,MadeiraSV,Soares de Moura R, 2003.Endothelium-dependent and -independent vasodilator effects of eugenol in the rat mesenteric vascular bed,J Pharm Pharmacol 55 359 -65
2009.Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes,Scand J Clin Lab Invest 69 85 -91
AchanV,BroadheadM,MalakiM,WhitleyG,LeiperJ,MacAllisterR, 2003.Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase,Arterioscler Thromb Vasc Biol 23 1455 -59
CriddleDN,MadeiraSV,Soares de Moura R, 2003.Endothelium-dependent and -independent vasodilator effects of eugenol in the rat mesenteric vascular bed,J Pharm Pharmacol 55 359 -65
VilbergssonS,SigurdssonG,SigvaldasonH,SigfussonN., .Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up,J Intern Med. -
Stroke, 1996., 27 1479 -86
NathanDM, .Treating type 2 diabetes with respect, -
1999.,Ann Intern Med 440 -41
AbbasiF,AsagmiT,CookeJP,LamendolaC,McLaughlinT,ReavenGM, .Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus,Am J Cardiol. -
WorthleyMI,HolmesAS,WilloughbySR,KuciaAM,HeresztynT,StewartS, 2007.The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration,J Am Coll Cardiol 304 -10
YasudaS,MiyazakiS,KandaM,GotoY,SuzukiM,HaranoY, 2006.Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase,Eur Heart J 27 1159 -65
AndersonJL,CarlquistJF,RobertsWL,HorneBD,MayHT,SchwarzEL, .Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: 30. Assessment of serum lipids in Nigerians with type 2 diabetes mellitus complications Pak J Med Sci, -
GordonL,RagoobirsinghD,MorrisonEY,ChooKangE,McGrowderD,MartorellE, 2010.Lipid profile of type 2 diabetic and hypertensive patients in the jamaican population,J Lab Physicians 2 25 -30
MortonJ,NgMK,ChalmersJ,WoodwardM,ManciaG,PoulterNR, 2013.The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? Cancer Epidemiol Biomarkers Prev, 22 1628 -33
CouillardC,DespresJP,LamarcheB,BergeronJ,GagnonJ,LeonAS, 2001.Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study,Arterioscler Thromb Vasc Biol 21 1226 -32
LamarcheB,DespresJP,MoorjaniS,CantinB,DagenaisGR,LupienPJ, .Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease, -
Atherosclerosis, 1996., 235 -45
AssmannG,SchulteH, 1992.Prospective Cardiovascular Munster study,Am J Cardiol 733 -37
0

Citations

0

Downloads

46

Views